Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for prevention of neonatal hyperbilirubinemia in mothers with blood group O
IRCT20200822048473N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fenofibrate in jaundice, sponsored by Babol University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
fenofibrate
03
Conditions
jaundice
Beyond the preview
Go deeper on IRCT20200822048473N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200822048473N1.